PharmaCyte Biotech, Inc. (PMCB) - OTCQB
  • PharmaBro | Send Message 26 May
    Reply (2)
    • PharmaBro | Send Message 26 May
    • PharmaBro | Send Message 26 May
      : More Conferences and decreasing short interest
      • John Persinos | Send Message 19 May

        Exciting Small-Cap Plays In The Smokin' Hot Marijuana Industry $VRTHF, $ZYNE, $PMCB http://seekingalpha.com/p/2wo8d
        Reply
          • kcortes | Send Message 18 May

            finally some light at the end of this circus around $PMCB http://tinyurl.com/jgz257w
            Reply (3)
          • View all 3 replies
            • markk100 | Send Message 19 May
              : While this is fine news, it means nothing to PMCB's success, nor the success of shareholders who are long.
            • markk100 | Send Message 19 May
              : They need action around trials, success in said trials, and a nod from the feds. Nothing else matters.
              • PharmaBro | Send Message 22 Apr
                Reply (4)
              • View all 4 replies
                • jayb2410 | Send Message 27 Apr
                  : i am with you at 300k average at .09....trying to get more...
                • rudygerner | Send Message 12 May
                  : I'm still here, adding and waiting for human pc trial, then sell a fraction of position and keep remaining shares for buyout/partnership.
                  • Drugdoctor | Send Message 1 Mar

                    $PXYN - $SBFM - $RXMD - $PMCB- $BIEI- Pharmas and BIOS with huge potential..
                    Reply (2)
                    • fdry | Send Message 1 Mar
                      : is there a priority ?
                    • Drugdoctor | Send Message 1 Mar
                      : $RCHAD was up 36% today...
                      • markk100 | Send Message 23 Feb

                        $PMCB Junk. They need to get their stuff straight. Get something going, one way or the other. Tired of their excuses...
                        Reply (4)
                      • View all 4 replies
                        • markk100 | Send Message 24 Feb
                          : Why bother selling for .05...just not worth it...If they catch some luck in trials, I win...if not I risk virtually nothing more. My .02
                        • Tile | Send Message 24 Feb
                          : I feel your pain. They don't have any ongoing study, never published anything on pancreatic cancer, and no partnership of any kind.
                          • PharmaBro | Send Message 25 Jan
                            Reply
                              • PharmaBro | Send Message 20 Jan

                                $PMCB I just noticed for the first time that there is institutional ownership, .07% by Fisher Asset Management.
                                Reply (2)
                                • PharmaBro | Send Message 20 Jan
                                  : They have a $36.4k position as of 12/31/2015
                                • matratra | Send Message 20 Jan
                                  : Fisher management, I would avoid it due to their ownership, which is not a fund but self proclaimed genius.
                                  • kevcls | Send Message 13 Jan
                                    Reply (5)
                                  • View all 5 replies
                                    • PharmaBro | Send Message 14 Jan
                                      : I was reading through that yesterday, my fidelity account and the NASDAQ site show no institutional ownership
                                    • PharmaBro | Send Message 14 Jan
                                      : I see that PMCB is speaking an event though, is institutional reporting different on the pink sheets than on the big exchanges?
                                      • PharmaBro | Send Message 12 Jan

                                        $PMCB Does anyone know of any institutional investors at this time? wasn't there a Chicago firm that invested a few years back??
                                        Reply
                                          Company Description
                                          PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box" This unique and patented technology will be... More
                                          Sector: Services
                                          Industry: Business Services
                                          Country: United States